Lim Jae-Hwan, West Katherine L, Rubinstein Yaffa, Bergel Michael, Postnikov Yuri V, Bustin Michael
Protein Section, Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
EMBO J. 2005 Sep 7;24(17):3038-48. doi: 10.1038/sj.emboj.7600768. Epub 2005 Aug 11.
The acetylation levels of lysine residues in nucleosomes, which are determined by the opposing activities of histone acetyltransferases (HATs) and deacetylases, play an important role in regulating chromatin-related processes, including transcription. We report that HMGN1, a nucleosomal binding protein that reduces the compaction of the chromatin fiber, increases the levels of acetylation of K14 in H3. The levels of H3K14ac in Hmgn1-/- cells are lower than in Hmgn1+/+ cells. Induced expression of wild-type HMGN1, but not of a mutant that does not bind to chromatin, in Hmgn1-/- cells elevates the levels of H3K14ac. In vivo, HMGN1 elevates the levels of H3K14ac by enhancing the action of HAT. In vitro, HMGN1 enhances the ability of PCAF to acetylate nucleosomal, but not free, H3. Thus, HMGN1 modulates the levels of H3K14ac by binding to chromatin. We suggest that HMGN1, and perhaps similar architectural proteins, modulates the levels of acetylation in chromatin by altering the equilibrium generated by the opposing enzymatic activities that continuously modify and de-modify the histone tails in nucleosomes.
核小体中赖氨酸残基的乙酰化水平由组蛋白乙酰转移酶(HATs)和去乙酰化酶的相反活性决定,在调节包括转录在内的染色质相关过程中起重要作用。我们报道,HMGN1是一种降低染色质纤维压缩程度的核小体结合蛋白,它能提高H3中K14的乙酰化水平。Hmgn1-/-细胞中H3K14ac的水平低于Hmgn1+/+细胞。在Hmgn1-/-细胞中诱导表达野生型HMGN1而非不与染色质结合的突变体,可提高H3K14ac的水平。在体内,HMGN1通过增强HAT的作用提高H3K14ac的水平。在体外,HMGN1增强了PCAF使核小体H3而非游离H3乙酰化的能力。因此,HMGN1通过与染色质结合来调节H3K14ac的水平。我们认为,HMGN1以及可能类似的结构蛋白,通过改变由持续修饰和去修饰核小体中组蛋白尾巴的相反酶活性所产生的平衡,来调节染色质中的乙酰化水平。